Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
about
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles.Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliterationAdenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection.A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantationCumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplantEarly plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndromeColonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation studyTie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus.Role of complement activation in obliterative bronchiolitis post-lung transplantation.Lung transplantation: infection, inflammation, and the microbiome.Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation.Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.Microhemorrhage-associated tissue iron enhances the risk for Aspergillus fumigatus invasion in a mouse model of airway transplantation.Lung Transplantation in Idiopathic Pulmonary Fibrosis
P2860
Q33572498-383AC990-C915-4578-A76A-5894E4B5252FQ34372089-8E4E9130-9805-4BEF-8DE5-A5EF20FBB673Q35015782-E1271AC6-07CE-4073-B913-4A15558E57B1Q35549729-0E83AAA5-4A92-4337-B051-97E8B61080BBQ36090184-B6DC9BE7-45EF-4350-8C27-8175B4372A84Q36640118-29380484-2821-4A65-B06B-C1BA92554E77Q36745407-D3D8B935-765F-48D9-9215-25558B96172EQ37142182-7B0E6728-70A8-4891-B4C4-BF0CE43CA190Q37414751-FE739CB8-6041-461B-8610-0ED2EF5DDD0AQ37832677-6977B6AC-EC46-4984-8A55-8A1D122C9CF6Q38296865-CCDF00B7-21A3-4BAA-AF9C-D7AA80D40679Q39176256-F1C73C2A-F28F-44F1-9FF7-45B835404E6DQ41930789-66146A6C-DBDF-4091-8B56-F74F43F008E7Q52793674-EACAAC81-7F4E-4926-9C34-893B68FE2679Q54269213-1E828060-D3AA-43B5-B9B3-6014448F0FA4Q58710324-2AB4A675-8C34-438F-9E37-F8669DC1EDA7
P2860
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@en
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@nl
type
label
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@en
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@nl
prefLabel
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@en
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@nl
P2093
P921
P356
P1476
Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
@en
P2093
Ariss Derhovanessian
John A Belperio
Joseph P Lynch
Rajan Saggar
Rajeev Saggar
S Samuel Weigt
W Dean Wallace
P304
P356
10.1055/S-0030-1249116
P577
2010-03-30T00:00:00Z